Table 4 Multivariable analysis of advanced adenoma detection rate (AADR) on initial screening colonoscopy performed on type 2 diabetes and non-diabetes patients.

From: Type 2 diabetes impacts colorectal adenoma detection in screening colonoscopy

Variable

Levels

Odds ratio

95% CI

P-value

Type 2 diabetes

Type 2 diabetes vs. non-diabetes

1.28

0.85–1.93

0.24

BMI kg/m²

Every 1 unit increase

1.03

1.01–1.05

0.0096

Smoking

Current vs. Never

1.94

1.34–2.81

0.0019

Current vs. Quit

1.62

1.09–2.42

Age (y)

Every 1 year increase

1.05

1.03–1.08

<0.0001

Sex

Male vs Female

2.4

1.79–3.22

<0.0001

Race

Black/AA vs. White/EA

0.83

0.47–1.5

0.55

Asian vs. White/EA

0.45

0.14–1.47

Other vs. White/EA

0.89

0.36–2.18

Hispanic

Hispanic vs. non-Hispanic

0.6

0.3–1.2

0.15

Family History of CRC

History vs. no history

1.16

0.64–2.13

0.62

Aspirin use

Yes vs No

0.74

0.49–1.11

0.15

Quality of colonoscopic prep

Good vs. Excellent

1.32

0.92–1.9

0.33

Fair vs. Excellent

0.98

0.49–1.97

Undocumented vs. Excellent

1.56

0.82–2.94

Fellow Involvement

Yes vs. No

1.11

0.78–1.58

0.58

Insurance

Commercial vs. Medicare

1.13

0.71–1.8

0.24

Commercial vs. Medicaid

0.72

0.5–1.04

Commercial vs. Self-Pay

0.63

0.25–1.59

  1. The estimated odds ratio and their 95% confidence intervals (CI) for each covariate were based on a fixed multivariable generalized linear mixed (GLMM) model on ADR. The p-values were based on type 3 analysis from the multivariable GLMM model. The p-values <0.05 are bolded.